Clinical Trial Update: Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer. [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating 18F Fluciclovine PET for cervical and endometrial (uterine) cancer has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer

Drugs mentioned

• 18F-Fluciclovine (fluorine-18-fluciclovine)

Snippet

Sponsor: Nghi Nguyen | Conditions: Cervical Cancer, Uterine Cancer | Phase 4 | Status: TERMINATED | Results posted: 2020-10-28